Patent · US Active

MTOR modulators and uses thereof

US9629843B2 · kind B2 · utility

16Cited by
152References
1Claims
0Family size

Assignees

Inventors

Key dates

Filing dateJun 5, 2015
Grant dateApr 25, 2017
Priority date
Expiry dateJun 5, 2035

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2510/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention provides methods and compositions for selective modulation of certain protein kinases, and especially mTor complexes. The methods and compositions are particularly useful in inhibiting mTor selectively for therapeutic applications.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.